Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cahill

Showing results (301-310 of 425) with videos related to

Pageof 43
Sort By:
The Oncologist|February 24, 2019
Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic ControlChristopher Alvarez-Breckenridge, Anita Giobbie-Hurder, Corey M Gill, et al.
Msphere|December 17, 2016
Temporal and Racial Differences Associated with Atopic Dermatitis <i>Staphylococcus</i><i>aureus</i> and Encoded Virulence FactorsJoseph A Merriman, Elizabeth A Mueller, Michael P Cahill, et al.
Nature Communications|April 18, 2018
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarateOvidiu C Andronesi, Isabel C Arrillaga-Romany, K Ina Ly, et al.
Journal of Neurosurgery|March 30, 2019
Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mappingBryan D Choi, Daniel K Lee, Jimmy C Yang, et al.
Cancer Cell|October 3, 2017
Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant GliomaChristian J Braun, Monica Stanciu, Paul L Boutz, et al.
Journal of Neuro-Oncology|November 21, 2014
Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastomaJennie W Taylor, Jorg Dietrich, Elizabeth R Gerstner, et al.
Neuro-Oncology|December 6, 2013
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resectionJason Beiko, Dima Suki, Kenneth R Hess, et al.
Acta Neuropathologica|February 22, 2015
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomasAdriana Olar, Khalida M Wani, Kristin D Alfaro-Munoz, et al.
Science (New York, N.Y.)|June 14, 2014
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastomaAnoop P Patel, Itay Tirosh, John J Trombetta, et al.
Neuro-Oncology|June 8, 2019
Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastasesFranziska Maria Ippen, Julia Katharina Grosch, Megha Subramanian, et al.
Pageof 43

Showing results (301-310 of 425) with videos related to

Sort By:
Pageof 43
The Oncologist|February 24, 2019
Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic ControlChristopher Alvarez-Breckenridge, Anita Giobbie-Hurder, Corey M Gill, et al.
Msphere|December 17, 2016
Temporal and Racial Differences Associated with Atopic Dermatitis <i>Staphylococcus</i><i>aureus</i> and Encoded Virulence FactorsJoseph A Merriman, Elizabeth A Mueller, Michael P Cahill, et al.
Nature Communications|April 18, 2018
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarateOvidiu C Andronesi, Isabel C Arrillaga-Romany, K Ina Ly, et al.
Journal of Neurosurgery|March 30, 2019
Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mappingBryan D Choi, Daniel K Lee, Jimmy C Yang, et al.
Cancer Cell|October 3, 2017
Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant GliomaChristian J Braun, Monica Stanciu, Paul L Boutz, et al.
Journal of Neuro-Oncology|November 21, 2014
Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastomaJennie W Taylor, Jorg Dietrich, Elizabeth R Gerstner, et al.
Neuro-Oncology|December 6, 2013
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resectionJason Beiko, Dima Suki, Kenneth R Hess, et al.
Acta Neuropathologica|February 22, 2015
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomasAdriana Olar, Khalida M Wani, Kristin D Alfaro-Munoz, et al.
Science (New York, N.Y.)|June 14, 2014
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastomaAnoop P Patel, Itay Tirosh, John J Trombetta, et al.
Neuro-Oncology|June 8, 2019
Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastasesFranziska Maria Ippen, Julia Katharina Grosch, Megha Subramanian, et al.
Pageof 43